Multiple objective data envelopment analysis as applied to the Indian Pharmaceutical Industry

• Published in: The Journal of the Operational Research Society Vol. 58; no. 11; pp. 1480 - 1493
• Main Author: Saranga, H
• Format: Journal Article
• Language: English
• Published: Abingdon Taylor & Francis 01-11-2007; Palgrave Macmillan Press; Taylor & Francis Ltd
• Subjects: Benchmarks; Business models; Business structures; Capital costs; Case-Oriented Papers; Cost control; Cost efficiency; Data envelopment analysis; Drug design; Drugs; Expenditures; Exports; Generic drugs; Industrialized nations; Intellectual property; Linear programming; Manufacturing; Modeling; Multinational corporations; multiple objective linear programming; Operations research; optimization; Patent law; Peer groups; Pharmaceutical industry; Pharmaceutical preparations; Production costs; Production efficiency; Reverse engineering; Strategic planning; Studies; Tariffs; India
• ISSN: 0160-5682; 1476-9360
• DOI: 10.1057/palgrave.jors.2602280

The change of Intellectual Property Protection (IPP) from a softer process patenting to a stronger product patenting in Indian Pharmaceutical Industry (IPI) is attracting many global drug majors to source their production from India, which is the fourth largest producer of pharmaceuticals in the world. In this paper, the interests of different stake holders like the buyers (multinational enterprises), who are searching for efficient partners and the vendors (Indian drug producers) that are competing for the contracts, are analysed for a suitable efficiency evaluation criterion. The primary objective of this paper is to study how various firms in the IPI with different business strategies, competing for the same opportunities can find suitable benchmarking peer groups to meet the challenges of a dynamic business environment using data envelopment analysis (DEA). A multiple objective DEA model that determines suitable peer groups for inefficient companies is discussed along with more traditional DEA models. The proposed model has the flexibility to include inputs like R&D expenditure and outputs like Exports that are not homogeneously distributed across the firms and address the interests of various stake holders like buyers and vendors simultaneously.